Figure 2From: The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort studyClinical breakdown of patients who underwent right heart catherisation (RHC). All patients screened positive to the current Australian Scleroderma Cohort Study; (ASCS) screening guidelines. FVC, forced vital capacity; HRCT, high-resolution computed tomography; ILD, interstitial lung disease; LHD, left heart disease; mPAP, mean pulmonary artery pressure; PAH, pulmonary arterial hypertension; PCWP, pulmonary capillary wedge pressure; PH, pulmonary hypertension; SSc, systemic sclerosis; WHO, World Health Organization.Back to article page